Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Merit Medical Systems ( (MMSI) ) has provided an announcement.
On October 15, 2025, Merit Medical Systems announced a definitive agreement to acquire the C2 CryoBalloon device and related technology from Pentax of America, Inc. for $22 million. This acquisition aims to enhance Merit’s endoscopy portfolio, particularly in the gastroenterology market, by providing innovative solutions for gastrointestinal disorders such as Barrett’s esophagus. The transaction is expected to close in the fourth quarter of 2025, with anticipated revenue contributions of $6 million to $8 million in 2026. The acquisition is projected to initially dilute Merit’s earnings but is expected to be accretive in the long term, strengthening its market position and expanding treatment options for patients.
The most recent analyst rating on (MMSI) stock is a Buy with a $104.00 price target. To see the full list of analyst forecasts on Merit Medical Systems stock, see the MMSI Stock Forecast page.
Spark’s Take on MMSI Stock
According to Spark, TipRanks’ AI Analyst, MMSI is a Outperform.
Merit Medical Systems demonstrates strong financial performance and positive earnings call sentiment, which are the most significant factors driving the score. Technical analysis suggests a neutral trend, while valuation concerns due to a high P/E ratio and no dividend yield slightly offset the positives. The company’s strategic initiatives and leadership changes support a positive outlook despite some market challenges.
To see Spark’s full report on MMSI stock, click here.
More about Merit Medical Systems
Merit Medical Systems, Inc. is a global leader in healthcare technology, specializing in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures across cardiology, radiology, oncology, critical care, and endoscopy. The company serves customers worldwide with a robust sales force and clinical support team.
Average Trading Volume: 621,544
Technical Sentiment Signal: Hold
Current Market Cap: $4.79B
For detailed information about MMSI stock, go to TipRanks’ Stock Analysis page.